EMEA (Europe, Middle East and Africa) Vasomotor Symptoms of Menopause Treatment Market Report 2018

January 2018 | 107 pages | ID: EC6F1136EC5EN
QYResearch

Abstracts

In this report, the EMEA Vasomotor Symptoms of Menopause Treatment market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Vasomotor Symptoms of Menopause Treatment for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Vasomotor Symptoms of Menopause Treatment market competition by top manufacturers/players, with Vasomotor Symptoms of Menopause Treatment sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Amgen Inc.
• EndoCeutics, Inc.
• Euroscreen S.A.
• MenoGeniX, Inc.
• Mithra Pharmaceuticals S.A.
• Pherin Pharmaceuticals, Inc.
• Pivot Pharmaceuticals Inc
• Radius Health, Inc.
• TherapeuticsMD, Inc.

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Estetrol
• Fezolinetant
• FP-101
• HBN-2
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Hospital
• Homecare
• Clinic

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Vasomotor Symptoms of Menopause Treatment Market Report 2017

1 VASOMOTOR SYMPTOMS OF MENOPAUSE TREATMENT OVERVIEW

1.1 Product Overview and Scope of Vasomotor Symptoms of Menopause Treatment
1.2 Classification of Vasomotor Symptoms of Menopause Treatment
  1.2.1 EMEA Vasomotor Symptoms of Menopause Treatment Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Vasomotor Symptoms of Menopause Treatment Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Estetrol
  1.2.4 Fezolinetant
  1.2.5 FP-101
  1.2.6 HBN-2
  1.2.7 Others
1.3 EMEA Vasomotor Symptoms of Menopause Treatment Market by Application/End Users
  1.3.1 EMEA Vasomotor Symptoms of Menopause Treatment Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Hospital
  1.3.3 Homecare
  1.3.4 Clinic
1.4 EMEA Vasomotor Symptoms of Menopause Treatment Market by Region
  1.4.1 EMEA Vasomotor Symptoms of Menopause Treatment Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Vasomotor Symptoms of Menopause Treatment (2012-2022)
  1.5.1 EMEA Vasomotor Symptoms of Menopause Treatment Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Vasomotor Symptoms of Menopause Treatment Revenue and Growth Rate (2012-2022)

2 EMEA VASOMOTOR SYMPTOMS OF MENOPAUSE TREATMENT COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Vasomotor Symptoms of Menopause Treatment Market Competition by Players/Manufacturers
  2.1.1 EMEA Vasomotor Symptoms of Menopause Treatment Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Vasomotor Symptoms of Menopause Treatment Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Vasomotor Symptoms of Menopause Treatment Sale Price by Players (2012-2017)
2.2 EMEA Vasomotor Symptoms of Menopause Treatment (Volume and Value) by Type/Product Category
  2.2.1 EMEA Vasomotor Symptoms of Menopause Treatment Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Vasomotor Symptoms of Menopause Treatment Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Vasomotor Symptoms of Menopause Treatment Sale Price by Type (2012-2017)
2.3 EMEA Vasomotor Symptoms of Menopause Treatment (Volume) by Application
2.4 EMEA Vasomotor Symptoms of Menopause Treatment (Volume and Value) by Region
  2.4.1 EMEA Vasomotor Symptoms of Menopause Treatment Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Vasomotor Symptoms of Menopause Treatment Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Vasomotor Symptoms of Menopause Treatment Sales Price by Region (2012-2017)

3 EUROPE VASOMOTOR SYMPTOMS OF MENOPAUSE TREATMENT (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Vasomotor Symptoms of Menopause Treatment Sales and Value (2012-2017)
  3.1.1 Europe Vasomotor Symptoms of Menopause Treatment Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Vasomotor Symptoms of Menopause Treatment Revenue and Growth Rate (2012-2017)
3.2 Europe Vasomotor Symptoms of Menopause Treatment Sales and Market Share by Type
3.3 Europe Vasomotor Symptoms of Menopause Treatment Sales and Market Share by Application
3.4 Europe Vasomotor Symptoms of Menopause Treatment Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Vasomotor Symptoms of Menopause Treatment Sales Volume by Countries (2012-2017)
  3.4.2 Europe Vasomotor Symptoms of Menopause Treatment Revenue by Countries (2012-2017)
  3.4.3 Germany Vasomotor Symptoms of Menopause Treatment Sales and Growth Rate (2012-2017)
  3.4.4 France Vasomotor Symptoms of Menopause Treatment Sales and Growth Rate (2012-2017)
  3.4.5 UK Vasomotor Symptoms of Menopause Treatment Sales and Growth Rate (2012-2017)
  3.4.6 Russia Vasomotor Symptoms of Menopause Treatment Sales and Growth Rate (2012-2017)
  3.4.7 Italy Vasomotor Symptoms of Menopause Treatment Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Vasomotor Symptoms of Menopause Treatment Sales and Growth Rate (2012-2017)

4 MIDDLE EAST VASOMOTOR SYMPTOMS OF MENOPAUSE TREATMENT (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Vasomotor Symptoms of Menopause Treatment Sales and Value (2012-2017)
  4.1.1 Middle East Vasomotor Symptoms of Menopause Treatment Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Vasomotor Symptoms of Menopause Treatment Revenue and Growth Rate (2012-2017)
4.2 Middle East Vasomotor Symptoms of Menopause Treatment Sales and Market Share by Type
4.3 Middle East Vasomotor Symptoms of Menopause Treatment Sales and Market Share by Application
4.4 Middle East Vasomotor Symptoms of Menopause Treatment Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Vasomotor Symptoms of Menopause Treatment Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Vasomotor Symptoms of Menopause Treatment Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Vasomotor Symptoms of Menopause Treatment Sales and Growth Rate (2012-2017)
  4.4.4 Israel Vasomotor Symptoms of Menopause Treatment Sales and Growth Rate (2012-2017)
  4.4.5 UAE Vasomotor Symptoms of Menopause Treatment Sales and Growth Rate (2012-2017)
  4.4.6 Iran Vasomotor Symptoms of Menopause Treatment Sales and Growth Rate (2012-2017)

5 AFRICA VASOMOTOR SYMPTOMS OF MENOPAUSE TREATMENT (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Vasomotor Symptoms of Menopause Treatment Sales and Value (2012-2017)
  5.1.1 Africa Vasomotor Symptoms of Menopause Treatment Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Vasomotor Symptoms of Menopause Treatment Revenue and Growth Rate (2012-2017)
5.2 Africa Vasomotor Symptoms of Menopause Treatment Sales and Market Share by Type
5.3 Africa Vasomotor Symptoms of Menopause Treatment Sales and Market Share by Application
5.4 Africa Vasomotor Symptoms of Menopause Treatment Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Vasomotor Symptoms of Menopause Treatment Sales Volume by Countries (2012-2017)
  5.4.2 Africa Vasomotor Symptoms of Menopause Treatment Revenue by Countries (2012-2017)
  5.4.3 South Africa Vasomotor Symptoms of Menopause Treatment Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Vasomotor Symptoms of Menopause Treatment Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Vasomotor Symptoms of Menopause Treatment Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Vasomotor Symptoms of Menopause Treatment Sales and Growth Rate (2012-2017)

6 EMEA VASOMOTOR SYMPTOMS OF MENOPAUSE TREATMENT MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Amgen Inc.
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Vasomotor Symptoms of Menopause Treatment Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Amgen Inc. Vasomotor Symptoms of Menopause Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 EndoCeutics, Inc.
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Vasomotor Symptoms of Menopause Treatment Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 EndoCeutics, Inc. Vasomotor Symptoms of Menopause Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Euroscreen S.A.
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Vasomotor Symptoms of Menopause Treatment Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Euroscreen S.A. Vasomotor Symptoms of Menopause Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 MenoGeniX, Inc.
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Vasomotor Symptoms of Menopause Treatment Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 MenoGeniX, Inc. Vasomotor Symptoms of Menopause Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Mithra Pharmaceuticals S.A.
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Vasomotor Symptoms of Menopause Treatment Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Mithra Pharmaceuticals S.A. Vasomotor Symptoms of Menopause Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Pherin Pharmaceuticals, Inc.
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Vasomotor Symptoms of Menopause Treatment Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Pherin Pharmaceuticals, Inc. Vasomotor Symptoms of Menopause Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Pivot Pharmaceuticals Inc
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Vasomotor Symptoms of Menopause Treatment Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Pivot Pharmaceuticals Inc Vasomotor Symptoms of Menopause Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Radius Health, Inc.
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Vasomotor Symptoms of Menopause Treatment Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Radius Health, Inc. Vasomotor Symptoms of Menopause Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 TherapeuticsMD, Inc.
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Vasomotor Symptoms of Menopause Treatment Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 TherapeuticsMD, Inc. Vasomotor Symptoms of Menopause Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview

7 VASOMOTOR SYMPTOMS OF MENOPAUSE TREATMENT MANUFACTURING COST ANALYSIS

7.1 Vasomotor Symptoms of Menopause Treatment Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Vasomotor Symptoms of Menopause Treatment

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Vasomotor Symptoms of Menopause Treatment Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Vasomotor Symptoms of Menopause Treatment Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA VASOMOTOR SYMPTOMS OF MENOPAUSE TREATMENT MARKET FORECAST (2017-2022)

11.1 EMEA Vasomotor Symptoms of Menopause Treatment Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Vasomotor Symptoms of Menopause Treatment Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Vasomotor Symptoms of Menopause Treatment Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Vasomotor Symptoms of Menopause Treatment Price and Trend Forecast (2017-2022)
11.2 EMEA Vasomotor Symptoms of Menopause Treatment Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Vasomotor Symptoms of Menopause Treatment Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Vasomotor Symptoms of Menopause Treatment Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Vasomotor Symptoms of Menopause Treatment Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Vasomotor Symptoms of Menopause Treatment Sales Forecast by Type (2017-2022)
11.7 EMEA Vasomotor Symptoms of Menopause Treatment Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Vasomotor Symptoms of Menopause Treatment
Figure EMEA Vasomotor Symptoms of Menopause Treatment Sales Volume (K Pcs) by Type (2012-2022)
Figure EMEA Vasomotor Symptoms of Menopause Treatment Sales Volume Market Share by Type (Product Category) in 2016
Figure Estetrol Product Picture
Figure Fezolinetant Product Picture
Figure FP-101 Product Picture
Figure HBN-2 Product Picture
Figure Others Product Picture
Figure EMEA Vasomotor Symptoms of Menopause Treatment Sales Volume (K Pcs) by Application (2012-2022)
Figure EMEA Sales Market Share of Vasomotor Symptoms of Menopause Treatment by Application in 2016
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Homecare Examples
Table Key Downstream Customer in Homecare
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure EMEA Vasomotor Symptoms of Menopause Treatment Market Size (Million USD) by Region (2012-2022)
Figure Europe Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) Status and Forecast by Countries
Figure Africa Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Vasomotor Symptoms of Menopause Treatment Sales Volume and Growth Rate (2012-2022)
Figure EMEA Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Vasomotor Symptoms of Menopause Treatment Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table EMEA Vasomotor Symptoms of Menopause Treatment Sales Volume (K Pcs) of Major Players (2012-2017)
Table EMEA Vasomotor Symptoms of Menopause Treatment Sales Share by Players (2012-2017)
Figure 2016 Vasomotor Symptoms of Menopause Treatment Sales Share by Players
Figure 2017 Vasomotor Symptoms of Menopause Treatment Sales Share by Players
Figure EMEA Vasomotor Symptoms of Menopause Treatment Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) by Players (2012-2017)
Table EMEA Vasomotor Symptoms of Menopause Treatment Revenue Share by Players (2012-2017)
Table 2016 EMEA Vasomotor Symptoms of Menopause Treatment Revenue Share by Players
Table 2017 EMEA Vasomotor Symptoms of Menopause Treatment Revenue Share by Players
Table EMEA Vasomotor Symptoms of Menopause Treatment Sale Price (USD/Pcs) by Players (2012-2017)
Table EMEA Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) and Market Share by Type (2012-2017)
Table EMEA Vasomotor Symptoms of Menopause Treatment Sales Share by Type (2012-2017)
Figure Sales Market Share of Vasomotor Symptoms of Menopause Treatment by Type (2012-2017)
Figure EMEA Vasomotor Symptoms of Menopause Treatment Sales Market Share by Type (2012-2017)
Table EMEA Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Vasomotor Symptoms of Menopause Treatment Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Vasomotor Symptoms of Menopause Treatment by Type in 2016
Table EMEA Vasomotor Symptoms of Menopause Treatment Sale Price (USD/Pcs) by Type (2012-2017)
Table EMEA Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) and Market Share by Application (2012-2017)
Table EMEA Vasomotor Symptoms of Menopause Treatment Sales Share by Application (2012-2017)
Figure Sales Market Share of Vasomotor Symptoms of Menopause Treatment by Application (2012-2017)
Figure EMEA Vasomotor Symptoms of Menopause Treatment Sales Market Share by Application in 2016
Table EMEA Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) and Market Share by Region (2012-2017)
Table EMEA Vasomotor Symptoms of Menopause Treatment Sales Share by Region (2012-2017)
Figure Sales Market Share of Vasomotor Symptoms of Menopause Treatment by Region (2012-2017)
Figure EMEA Vasomotor Symptoms of Menopause Treatment Sales Market Share in 2016
Table EMEA Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Vasomotor Symptoms of Menopause Treatment Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Vasomotor Symptoms of Menopause Treatment by Region (2012-2017)
Figure EMEA Vasomotor Symptoms of Menopause Treatment Revenue Market Share Regions in 2016
Table EMEA Vasomotor Symptoms of Menopause Treatment Sales Price (USD/Pcs) by Region (2012-2017)
Figure Europe Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure Europe Vasomotor Symptoms of Menopause Treatment Revenue and Growth Rate (2012-2017)
Table Europe Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) by Type (2012-2017)
Table Europe Vasomotor Symptoms of Menopause Treatment Market Share by Type (2012-2017)
Figure Europe Vasomotor Symptoms of Menopause Treatment Market Share by Type in 2016
Table Europe Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) by Application (2012-2017)
Table Europe Vasomotor Symptoms of Menopause Treatment Market Share by Application (2012-2017)
Figure Europe Vasomotor Symptoms of Menopause Treatment Market Share by Application in 2016
Table Europe Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) by Countries (2012-2017)
Table Europe Vasomotor Symptoms of Menopause Treatment Sales Market Share by Countries (2012-2017)
Figure Europe Vasomotor Symptoms of Menopause Treatment Sales Market Share by Countries (2012-2017)
Figure Europe Vasomotor Symptoms of Menopause Treatment Sales Market Share by Countries in 2016
Table Europe Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) by Countries (2012-2017)
Table Europe Vasomotor Symptoms of Menopause Treatment Revenue Market Share by Countries (2012-2017)
Figure Europe Vasomotor Symptoms of Menopause Treatment Revenue Market Share by Countries (2012-2017)
Figure Europe Vasomotor Symptoms of Menopause Treatment Revenue Market Share by Countries in 2016
Figure Germany Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure France Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure UK Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure Russia Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure Italy Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure Benelux Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) by Type (2012-2017)
Table Middle East Vasomotor Symptoms of Menopause Treatment Market Share by Type (2012-2017)
Figure Middle East Vasomotor Symptoms of Menopause Treatment Market Share by Type (2012-2017)
Table Middle East Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) by Applications (2012-2017)
Table Middle East Vasomotor Symptoms of Menopause Treatment Market Share by Applications (2012-2017)
Figure Middle East Vasomotor Symptoms of Menopause Treatment Sales Market Share by Application in 2016
Table Middle East Vasomotor Symptoms of Menopause Treatment Sales Volume (K Pcs) by Countries (2012-2017)
Table Middle East Vasomotor Symptoms of Menopause Treatment Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Vasomotor Symptoms of Menopause Treatment Sales Volume Market Share by Countries in 2016
Table Middle East Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) by Countries (2012-2017)
Table Middle East Vasomotor Symptoms of Menopause Treatment Revenue Market Share by Countries (2012-2017)
Figure Middle East Vasomotor Symptoms of Menopause Treatment Revenue Market Share by Countries (2012-2017)
Figure Middle East Vasomotor Symptoms of Menopause Treatment Revenue Market Share by Countries in 2016
Figure Saudi Arabia Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure Israel Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure UAE Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure Iran Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) by Type (2012-2017)
Table Africa Vasomotor Symptoms of Menopause Treatment Sales Market Share by Type (2012-2017)
Figure Africa Vasomotor Symptoms of Menopause Treatment Sales Market Share by Type (2012-2017)
Figure Africa Vasomotor Symptoms of Menopause Treatment Sales Market Share by Type in 2016
Table Africa Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) by Application (2012-2017)
Table Africa Vasomotor Symptoms of Menopause Treatment Sales Market Share by Application (2012-2017)
Figure Africa Vasomotor Symptoms of Menopause Treatment Sales Market Share by Application (2012-2017)
Table Africa Vasomotor Symptoms of Menopause Treatment Sales Volume (K Pcs) by Countries (2012-2017)
Table Africa Vasomotor Symptoms of Menopause Treatment Sales Market Share by Countries (2012-2017)
Figure Africa Vasomotor Symptoms of Menopause Treatment Sales Market Share by Countries (2012-2017)
Figure Africa Vasomotor Symptoms of Menopause Treatment Sales Market Share by Countries in 2016
Table Africa Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) by Countries (2012-2017)
Table Africa Vasomotor Symptoms of Menopause Treatment Revenue Market Share by Countries (2012-2017)
Figure Africa Vasomotor Symptoms of Menopause Treatment Revenue Market Share by Countries (2012-2017)
Figure Africa Vasomotor Symptoms of Menopause Treatment Revenue Market Share by Countries in 2016
Figure South Africa Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure Nigeria Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure Egypt Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure Algeria Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Table Amgen Inc. Vasomotor Symptoms of Menopause Treatment Basic Information List
Table Amgen Inc. Vasomotor Symptoms of Menopause Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Amgen Inc. Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure Amgen Inc. Vasomotor Symptoms of Menopause Treatment Sales Market Share in EMEA (2012-2017)
Figure Amgen Inc. Vasomotor Symptoms of Menopause Treatment Revenue Market Share in EMEA (2012-2017)
Table EndoCeutics, Inc. Vasomotor Symptoms of Menopause Treatment Basic Information List
Table EndoCeutics, Inc. Vasomotor Symptoms of Menopause Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure EndoCeutics, Inc. Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure EndoCeutics, Inc. Vasomotor Symptoms of Menopause Treatment Sales Market Share in EMEA (2012-2017)
Figure EndoCeutics, Inc. Vasomotor Symptoms of Menopause Treatment Revenue Market Share in EMEA (2012-2017)
Table Euroscreen S.A. Vasomotor Symptoms of Menopause Treatment Basic Information List
Table Euroscreen S.A. Vasomotor Symptoms of Menopause Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Euroscreen S.A. Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure Euroscreen S.A. Vasomotor Symptoms of Menopause Treatment Sales Market Share in EMEA (2012-2017)
Figure Euroscreen S.A. Vasomotor Symptoms of Menopause Treatment Revenue Market Share in EMEA (2012-2017)
Table MenoGeniX, Inc. Vasomotor Symptoms of Menopause Treatment Basic Information List
Table MenoGeniX, Inc. Vasomotor Symptoms of Menopause Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure MenoGeniX, Inc. Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure MenoGeniX, Inc. Vasomotor Symptoms of Menopause Treatment Sales Market Share in EMEA (2012-2017)
Figure MenoGeniX, Inc. Vasomotor Symptoms of Menopause Treatment Revenue Market Share in EMEA (2012-2017)
Table Mithra Pharmaceuticals S.A. Vasomotor Symptoms of Menopause Treatment Basic Information List
Table Mithra Pharmaceuticals S.A. Vasomotor Symptoms of Menopause Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Mithra Pharmaceuticals S.A. Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure Mithra Pharmaceuticals S.A. Vasomotor Symptoms of Menopause Treatment Sales Market Share in EMEA (2012-2017)
Figure Mithra Pharmaceuticals S.A. Vasomotor Symptoms of Menopause Treatment Revenue Market Share in EMEA (2012-2017)
Table Pherin Pharmaceuticals, Inc. Vasomotor Symptoms of Menopause Treatment Basic Information List
Table Pherin Pharmaceuticals, Inc. Vasomotor Symptoms of Menopause Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Pherin Pharmaceuticals, Inc. Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure Pherin Pharmaceuticals, Inc. Vasomotor Symptoms of Menopause Treatment Sales Market Share in EMEA (2012-2017)
Figure Pherin Pharmaceuticals, Inc. Vasomotor Symptoms of Menopause Treatment Revenue Market Share in EMEA (2012-2017)
Table Pivot Pharmaceuticals Inc Vasomotor Symptoms of Menopause Treatment Basic Information List
Table Pivot Pharmaceuticals Inc Vasomotor Symptoms of Menopause Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Pivot Pharmaceuticals Inc Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure Pivot Pharmaceuticals Inc Vasomotor Symptoms of Menopause Treatment Sales Market Share in EMEA (2012-2017)
Figure Pivot Pharmaceuticals Inc Vasomotor Symptoms of Menopause Treatment Revenue Market Share in EMEA (2012-2017)
Table Radius Health, Inc. Vasomotor Symptoms of Menopause Treatment Basic Information List
Table Radius Health, Inc. Vasomotor Symptoms of Menopause Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Radius Health, Inc. Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure Radius Health, Inc. Vasomotor Symptoms of Menopause Treatment Sales Market Share in EMEA (2012-2017)
Figure Radius Health, Inc. Vasomotor Symptoms of Menopause Treatment Revenue Market Share in EMEA (2012-2017)
Table TherapeuticsMD, Inc. Vasomotor Symptoms of Menopause Treatment Basic Information List
Table TherapeuticsMD, Inc. Vasomotor Symptoms of Menopause Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure TherapeuticsMD, Inc. Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) and Growth Rate (2012-2017)
Figure TherapeuticsMD, Inc. Vasomotor Symptoms of Menopause Treatment Sales Market Share in EMEA (2012-2017)
Figure TherapeuticsMD, Inc. Vasomotor Symptoms of Menopause Treatment Revenue Market Share in EMEA (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Vasomotor Symptoms of Menopause Treatment
Figure Manufacturing Process Analysis of Vasomotor Symptoms of Menopause Treatment
Figure Vasomotor Symptoms of Menopause Treatment Industrial Chain Analysis
Table Raw Materials Sources of Vasomotor Symptoms of Menopause Treatment Major Manufacturers in 2016
Table Major Buyers of Vasomotor Symptoms of Menopause Treatment
Table Distributors/Traders List
Figure EMEA Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure EMEA Vasomotor Symptoms of Menopause Treatment Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Vasomotor Symptoms of Menopause Treatment Price (USD/Pcs) and Trend Forecast (2017-2022)
Table EMEA Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) Forecast by Region (2017-2022)
Figure EMEA Vasomotor Symptoms of Menopause Treatment Sales Market Share Forecast by Region (2017-2022)
Table EMEA Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Vasomotor Symptoms of Menopause Treatment Revenue Market Share Forecast by Region (2017-2022)
Table Europe Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Europe Vasomotor Symptoms of Menopause Treatment Sales Market Share Forecast by Countries (2017-2022)
Table Europe Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Vasomotor Symptoms of Menopause Treatment Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Middle East Vasomotor Symptoms of Menopause Treatment Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Vasomotor Symptoms of Menopause Treatment Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Africa Vasomotor Symptoms of Menopause Treatment Sales Market Share Forecast by Countries (2017-2022)
Table Africa Vasomotor Symptoms of Menopause Treatment Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Vasomotor Symptoms of Menopause Treatment Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) Forecast by Type (2017-2022)
Figure EMEA Vasomotor Symptoms of Menopause Treatment Sales Market Share Forecast by Type (2017-2022)
Table EMEA Vasomotor Symptoms of Menopause Treatment Sales (K Pcs) Forecast by Application (2017-2022)
Figure EMEA Vasomotor Symptoms of Menopause Treatment Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources